LYTIR

Company · CRBP

Corbus Pharmaceuticals Holdings, Inc.

Nasdaq's symbol directory lists CRBP on Nasdaq as “Corbus Pharmaceuticals Holdings, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($25K); insiders sold on 4 occasions ($2.1M); 5 filings by holders of 5% or more; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $25K in total; Insider sales: $2.1M in total.Aug: Insider purchases $25KAug: Insider sales $292KSep: Insider sales $16KOct: Insider sales $1.7MDecJanFebMarAprMayJunJulAugSepOctNov$25K$1.7M
Insider purchases above the line: $25KInsider sales below: $2.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Cormorant Asset Management, LP sold on 1 day latest Oct 29, 2026 sold $1.7M
  2. Cohen Yuval, Chief Executive Officer sold on 1 day all under a 10b5-1 plan latest Aug 7, 2026 sold $171K
  3. Moran Sean F., Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Aug 7, 2026 sold $121K
  4. Nishant C. Saxena, Chief Business Officer bought on 1 day latest Aug 11, 2026 bought $25K
  5. Ben Yong sold on 1 day all under a 10b5-1 plan latest Sep 14, 2026 sold $16K
Every trade (5)
  1. SELLCormorant Asset Management, LP sold Oct 29, 2026 425,000 shares filing $1.7M
  2. SELLBen Yong sold Sep 14, 2026 2,000 shares 10b5-1 plan (scheduled) filing $16K
  3. BUYNishant C. Saxena, Chief Business Officer bought Aug 11, 2026 2,600 shares filing $25K
  4. SELLCohen Yuval, Chief Executive Officer sold Aug 7, 2026 17,000 shares 10b5-1 plan (scheduled) filing $171K
  5. SELLMoran Sean F., Chief Financial Officer sold Aug 7, 2026 12,000 shares 10b5-1 plan (scheduled) filing $121K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. MPM BioImpact LLC filed Nov 13, 2026 Schedule 13G passive 1,667,272 shares filing 8.6%
  2. Cormorant Asset Management, LP filed Nov 2, 2026 Schedule 13G/A passive 1,500,000 shares filing 7.76%
  3. Aberdeen Group plc filed Oct 29, 2026 Schedule 13G/A passive 0 shares filing 0%
  4. RA Capital Management, L.P. filed Sep 30, 2026 Schedule 13G passive filing 9.9%
  5. Citadel Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive filing 1.1%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure; Other events filing Nov 16, 2026
  2. Results of operations and financial condition; Regulation FD disclosure filing Nov 10, 2026
  3. Regulation FD disclosure filing Oct 15, 2026
  4. Regulation FD disclosure; Other events filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.